IRF
IONS icon

IBM Retirement Fund’s Ionis Pharmaceuticals IONS Stock Holding History

IBM Retirement Fund’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,462
Closed -$201K – 769
2021
Q1 		$201K Sell
4,462
-424
-9% -$23.6K 0.01% 763
2020
Q4 		$276K Buy
4,886
+640
+15% +$31.9K 0.02% 647
2020
Q3 		$201K Buy
+4,246
New +$236K 0.02% 651
2017
Q1 		– Sell
-9,633
Closed -$461K – 533
2016
Q4 		$461K Sell
9,633
-1,780
-16% -$70.4K 0.02% 608
2016
Q3 		$418K Sell
11,413
-749
-6% -$23.4K 0.02% 705
2016
Q2 		$283K Buy
12,162
+110
+0.9% +$3.55K 0.01% 872
2016
Q1 		$488K Sell
12,052
-17,129
-59% -$696K 0.02% 662
2015
Q4 		$1.81M Buy
29,181
+8,601
+42% +$464K 0.03% 526
2015
Q3 		$832K Sell
20,580
-3,649
-15% -$189K 0.02% 720
2015
Q2 		$1.39M Buy
+24,229
New +$1.54M 0.03% 618

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

IBM Retirement Fund's IONS Position: Q2 2021 in Review

IBM Retirement Fund sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 4,462 shares — an estimated $201K sold.

IBM Retirement Fund first reported a position in IONS in Q2 2015 and held it in 10 quarters. The position peaked at $1.81M in Q4 2015. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • IBM Retirement Fund reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • IBM Retirement Fund sold 4,462 Ionis Pharmaceuticals shares in Q2 2021, an estimated $201K.
  • IBM Retirement Fund first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 10 quarters.
  • IBM Retirement Fund's Ionis Pharmaceuticals position peaked at $1.81M in Q4 2015.
  • 337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on IBM Retirement Fund's 13F filing for Q2 2021, filed 12 Jul 2021.